Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + Dexamethasone in Newly Diagnosed MM
NCT00057564Phase 3Completed
- Sponsor
- Celgene Corporation
- Start
- Feb 2003
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Feb 2003; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00057564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057564.